person · Reporting owner

Hassan Fred

Disclosed activity across 8 companies

Tapewire entity: 11868
SEC CIK: 0001110744

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
AMGEN INCAMGN · Entity 2832	Director	May 05, 2020	May 08, 2020
BridgeBio Pharma, Inc.BBIO · Entity 3360	Director	June 22, 2026	June 24, 2026
Cocrystal Pharma, Inc.COCP · Entity 7621	Director	January 09, 2026	January 13, 2026
EyePoint, Inc.EYPT · Entity 5702	Director	January 02, 2026	January 06, 2026
PRECIGEN, INC.PGEN · Entity 4356	Director	March 13, 2026	March 16, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AMGEN INC

Report date May 05, 2020 · Filed May 08, 2020

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	9,191	Reported balance After 2020-05-05 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2020-05-05 · Grant · Acquired 846 · Balance 9,191 F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

Filing footnotes · ownership attribution and instrument terms

F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

BridgeBio Pharma, Inc.

Report date June 22, 2026 · Filed June 24, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	29,879	Reported balance After 2026-06-22 transaction · row 1 1 source row Row 1 · 2026-06-22 · Grant · Acquired 3,990 · Balance 29,879 F1: Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date. F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $68.92 · Expires 2036-06-21	Direct	5,277	Reported balance After 2026-06-22 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-06-22 · Grant · Acquired 5,277 · Balance 5,277 F3: The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.

F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F3: The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.

Cocrystal Pharma, Inc.

Report date January 09, 2026 · Filed January 13, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.10 · Expires 2036-01-09	Direct	16,410	Reported balance After 2026-01-09 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-01-09 · Grant · Acquired 16,410 · Balance 16,410 F1: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Compensation Committee of the Board of Directors. The non-qualified stock options are granted under the Issuer's 2025 Equity Incentive Plan and the exercisability shall be subject to execution of the Issuer's form of Non-Qualified Stock Option Agreement. The non-qualified stock options shall vest as follows: one-half shall vest and become exercisable on January 9, 2027 and the remaining half shall vest and become exercisable in eight equal quarterly installments commencing on March 31, 2027, subject to the Reporting Person continuing to serve as a director of the Issuer on each applicable vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Compensation Committee of the Board of Directors. The non-qualified stock options are granted under the Issuer's 2025 Equity Incentive Plan and the exercisability shall be subject to execution of the Issuer's form of Non-Qualified Stock Option Agreement. The non-qualified stock options shall vest as follows: one-half shall vest and become exercisable on January 9, 2027 and the remaining half shall vest and become exercisable in eight equal quarterly installments commencing on March 31, 2027, subject to the Reporting Person continuing to serve as a director of the Issuer on each applicable vesting date.

EyePoint, Inc.

Report date January 02, 2026 · Filed January 06, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.48 · Expires 2036-01-02	Direct	40,000	Reported balance After 2026-01-02 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-01-02 · Grant · Acquired 40,000 · Balance 40,000

PRECIGEN, INC.

Report date March 13, 2026 · Filed March 16, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,243,239	Reported balance After 2026-03-13 transaction · row 1 1 source row Row 1 · 2026-03-13 · Exercise / conversion · Acquired 71,839 · Balance 1,243,239 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2026-03-13 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-03-13 · Exercise / conversion · Disposed 71,839 · Balance 0 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2: The RSUs vested in full on March 13, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

F2: The RSUs vested in full on March 13, 2026.

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Merck & Co., Inc.

Report date November 03, 2009 · Filed November 04, 2009

Section 16 reporting ended · disclosed 2009-11-04. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common SharesSEC Table I · non-derivative	Direct	Reported balance After 2009-11-03 transaction · row 1 1 source row Row 1 · 2009-11-03 · Disposition to issuer · Disposed 935,400 · Balance 0 F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash.
Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.43 · Expires 2013-04-19	Direct	Reported balance After 2009-11-03 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2009-11-03 · Disposition to issuer · Disposed 900,000 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter.
Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.23 · Expires 2013-05-18	Direct	Reported balance After 2009-11-03 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2009-11-03 · Disposition to issuer · Disposed 1,000,000 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter.
Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.57 · Expires 2014-04-30	Direct	Reported balance After 2009-11-03 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2009-11-03 · Disposition to issuer · Disposed 1,180,000 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter.
Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.70 · Expires 2015-04-24	Direct	Reported balance After 2009-11-03 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2009-11-03 · Disposition to issuer · Disposed 1,100,000 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter.
Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.85 · Expires 2015-04-30	Direct	Reported balance After 2009-11-03 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2009-11-03 · Disposition to issuer · Disposed 836,000 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter.
Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.91 · Expires 2016-04-30	Direct	Reported balance After 2009-11-03 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2009-11-03 · Disposition to issuer · Disposed 868,300 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter.
Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.20 · Expires 2014-02-22	Direct	Reported balance After 2009-11-03 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2009-11-03 · Disposition to issuer · Disposed 1,100,000 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter.
Phantom Stock UnitSEC Table II · derivative / convertible security	Direct	Reported balance After 2009-11-03 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2009-11-03 · Disposition to issuer · Disposed 196,761.57 · Balance 0 F4: Each unit of phantom stock is the economic equivalent of one share of common stock. F5: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash.

F2: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter.

F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement.

F4: Each unit of phantom stock is the economic equivalent of one share of common stock.

F5: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan.

Prometheus Biosciences, Inc.

Report date June 16, 2023 · Filed June 16, 2023

Section 16 reporting ended · disclosed 2023-06-16. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2023-06-16 transaction · row 1 1 source row Row 1 · 2023-06-16 · Disposition to issuer · Disposed 2,123 · Balance 0 F1: Reflects restricted stock units. F2: Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. ("Merck") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the "Effective Time"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the "Merger Consideration"), without interest,.. (Continued in Footnote 3) F3: (Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units ("RSUs") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.82 · Expires 2031-05-13	Direct	Reported balance After 2023-06-16 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2023-06-16 · Disposition to issuer · Disposed 40,000 · Balance 0 F2: Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. ("Merck") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the "Effective Time"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the "Merger Consideration"), without interest,.. (Continued in Footnote 3) F3: (Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units ("RSUs") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.32 · Expires 2031-11-13	Direct	Reported balance After 2023-06-16 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2023-06-16 · Disposition to issuer · Disposed 541 · Balance 0 F2: Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. ("Merck") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the "Effective Time"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the "Merger Consideration"), without interest,.. (Continued in Footnote 3) F3: (Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units ("RSUs") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.02 · Expires 2032-05-18	Direct	Reported balance After 2023-06-16 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2023-06-16 · Disposition to issuer · Disposed 21,013 · Balance 0 F2: Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. ("Merck") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the "Effective Time"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the "Merger Consideration"), without interest,.. (Continued in Footnote 3) F3: (Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units ("RSUs") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects restricted stock units.

F2: Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. ("Merck") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the "Effective Time"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the "Merger Consideration"), without interest,.. (Continued in Footnote 3)

F3: (Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units ("RSUs") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option.

WARNER MEDIA, LLC

Report date June 14, 2018 · Filed June 18, 2018

Section 16 reporting ended · disclosed 2018-06-18. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common Stock, Par Value $.01SEC Table I · non-derivative	Direct	Reported balance After 2018-06-14 transaction · row 1 1 source row Row 1 · 2018-06-14 · Disposition to issuer · Disposed 49,089 · Balance 0 F1: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition.
Director Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.39 · Expires 2019-10-28	Direct	Reported balance After 2018-06-14 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2018-06-14 · Disposition to issuer · Disposed 4,019 · Balance 0 F1: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F2: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757).
Director Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.84 · Expires 2020-05-21	Direct	Reported balance After 2018-06-14 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2018-06-14 · Disposition to issuer · Disposed 5,708 · Balance 0 F1: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F2: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757).
Director Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.81 · Expires 2022-05-15	Direct	Reported balance After 2018-06-14 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2018-06-14 · Disposition to issuer · Disposed 5,336 · Balance 0 F1: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F2: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757).
Director Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $35.27 · Expires 2021-05-20	Direct	Reported balance After 2018-06-14 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2018-06-14 · Disposition to issuer · Disposed 4,880 · Balance 0 F1: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F2: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757).
Director Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $67.84 · Expires 2024-06-13	Direct	Reported balance After 2018-06-14 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2018-06-14 · Disposition to issuer · Disposed 2,898 · Balance 0 F1: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F2: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757).
Director Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.83 · Expires 2023-05-23	Direct	Reported balance After 2018-06-14 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2018-06-14 · Disposition to issuer · Disposed 2,996 · Balance 0 F1: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F2: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757).
Director Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $72.37 · Expires 2026-06-17	Direct	Reported balance After 2018-06-14 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2018-06-14 · Disposition to issuer · Disposed 3,108 · Balance 0 F1: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F2: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757).
Director Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $88.00 · Expires 2025-06-19	Direct	Reported balance After 2018-06-14 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2018-06-14 · Disposition to issuer · Disposed 2,460 · Balance 0 F1: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F2: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757).
Phantom Stock UnitsSEC Table II · derivative / convertible security · Expires 2018-06-14	IndirectBy Deferred Compensation Plan	Reported balance After 2018-06-14 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2018-06-14 · Disposition to issuer · Disposed 1,128.3387 · Balance 0 F3: Pursuant to the Merger Agreement, each outstanding phantom stock unit with respect to the Company's common stock acquired pursuant to the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") was deemed converted into an amount in cash equal to approximately $100.8845 and reinvested in the investment option under the Deferred Compensation Plan that earns interest at a specified rate. Pursuant to the terms of the Deferred Compensation Plan, the amount credited to the account will be paid out in cash in a lump sum or in annual installments beginning on April 30, 2019. F1: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition.

Filing footnotes · ownership attribution and instrument terms

F1: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition.

F2: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757).

F3: Pursuant to the Merger Agreement, each outstanding phantom stock unit with respect to the Company's common stock acquired pursuant to the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") was deemed converted into an amount in cash equal to approximately $100.8845 and reinvested in the investment option under the Deferred Compensation Plan that earns interest at a specified rate. Pursuant to the terms of the Deferred Compensation Plan, the amount credited to the account will be paid out in cash in a lump sum or in annual installments beginning on April 30, 2019.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 14, 2021 Filed May 17, 2021 23:24 UTC	Prometheus Biosciences, Inc. RXDX · Entity 112175	GrantStock Option (Right to Buy) · Derivative	40,000	$0.00 Strike: $16.82	$0.00	Disclosure SEC source: 0001209191-21-033308 · doc4.xml · derivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-05-13 F1 · derivative.exercise_date: The shares subject to the option will vest in substantially equal monthly installments over three years, commencing on May 14, 2021, subject to the Reporting Person's continued service with the Issuer through each vest date. Read SEC document
March 25, 2021 Filed Mar 29, 2021 23:46 UTC	PRECIGEN, INC. PGEN · Entity 4356	GrantOption to Purchase Common Stock (Right to Buy) · Derivative	22,107	$0.00 Strike: $7.71	$0.00	Disclosure SEC source: 0001123292-21-000565 · edgar.xml · derivative · entry 3 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,107 Underlying: Common Stock · 22,107 shares Expires 2031-03-25 Read SEC document
March 25, 2021 Filed Mar 29, 2021 23:46 UTC	PRECIGEN, INC. PGEN · Entity 4356	GrantRestricted Stock Units · Derivative	16,212	$0.00	$0.00	Disclosure SEC source: 0001123292-21-000565 · edgar.xml · derivative · entry 2 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,212 Underlying: Common Stock · 16,212 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Precigen, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on March 25, 2022. F3 · derivative.expiration_date: The restricted stock units vest in full on March 25, 2022. Read SEC document
March 25, 2021 Filed Mar 29, 2021 23:46 UTC	PRECIGEN, INC. PGEN · Entity 4356	GrantCommon Stock	7,328	$7.71	$56,498.88	Disclosure SEC source: 0001123292-21-000565 · edgar.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,687 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $56,500. Read SEC document
March 13, 2021 Filed Mar 16, 2021 20:35 UTC	PRECIGEN, INC. PGEN · Entity 4356	Exercise / conversionRestricted Stock Units · Derivative	62,189	$0.00	$0.00	Disclosure SEC source: 0001123292-21-000487 · edgar.xml · derivative · entry 2 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 13, 2021. F2 · derivative.expiration_date: The RSUs vested in full on March 13, 2021. Read SEC document
March 13, 2021 Filed Mar 16, 2021 20:35 UTC	PRECIGEN, INC. PGEN · Entity 4356	Exercise / conversionCommon Stock	62,189	Not disclosed	Not disclosed	Disclosure SEC source: 0001123292-21-000487 · edgar.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. Read SEC document
May 05, 2020 Filed May 8, 2020 00:40 UTC	AMGEN INC AMGN · Entity 2832	GrantCommon Stock	846	$0.00	$0.00	Disclosure SEC source: 0001127602-20-015851 · form4.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,191 F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. Read SEC document
March 13, 2020 Filed Mar 17, 2020 22:32 UTC	PRECIGEN, INC. PGEN · Entity 4356	GrantOption to Purchase Common Stock (Right to Buy) · Derivative	96,324	$0.00 Strike: $2.01	$0.00	Disclosure SEC source: 0001123292-20-000568 · edgar.xml · derivative · entry 3 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,324 Underlying: Common Stock · 96,324 shares Expires 2030-03-13 Read SEC document
March 13, 2020 Filed Mar 17, 2020 22:32 UTC	PRECIGEN, INC. PGEN · Entity 4356	GrantRestricted Stock Units · Derivative	62,189	$0.00	$0.00	Disclosure SEC source: 0001123292-20-000568 · edgar.xml · derivative · entry 2 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,189 Underlying: Common Stock · 62,189 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Precigen, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on March 13, 2021. F3 · derivative.expiration_date: The restricted stock units vest in full on March 13, 2021. Read SEC document
March 13, 2020 Filed Mar 17, 2020 22:32 UTC	PRECIGEN, INC. PGEN · Entity 4356	GrantCommon Stock	28,109	$2.01	$56,499.09	Disclosure SEC source: 0001123292-20-000568 · edgar.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,170 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $ 56,500. Read SEC document
March 08, 2020 Filed Mar 10, 2020 20:18 UTC	PRECIGEN, INC. PGEN · Entity 4356	Exercise / conversionRestricted Stock Units · Derivative	24,703	$0.00	$0.00	Disclosure SEC source: 0001123292-20-000537 · edgar.xml · derivative · entry 2 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,703 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F2 · derivative.exercise_date: The restricted stock units vested in full on March 8, 2020. F2 · derivative.expiration_date: The restricted stock units vested in full on March 8, 2020. Read SEC document
March 08, 2020 Filed Mar 10, 2020 20:18 UTC	PRECIGEN, INC. PGEN · Entity 4356	Exercise / conversionCommon Stock	24,703	Not disclosed	Not disclosed	Disclosure SEC source: 0001123292-20-000537 · edgar.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. Read SEC document
May 03, 2019 Filed May 7, 2019 22:21 UTC	AMGEN INC AMGN · Entity 2832	GrantCommon Stock	1,127	$0.00	$0.00	Disclosure SEC source: 0001127602-19-017638 · form4.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,345 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. Read SEC document
March 23, 2019 Filed Mar 26, 2019 21:49 UTC	PRECIGEN, INC. XON · Entity 4356	Exercise / conversionRestricted Stock Units · Derivative	7,911	$0.00	$0.00	Disclosure SEC source: 0001123292-19-000572 · edgar.xml · derivative · entry 2 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,911 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F2 · derivative.exercise_date: The restricted stock units vested in full on March 23, 2019. F2 · derivative.expiration_date: The restricted stock units vested in full on March 23, 2019. Read SEC document
March 23, 2019 Filed Mar 26, 2019 21:49 UTC	PRECIGEN, INC. XON · Entity 4356	Exercise / conversionCommon Stock	7,911	Not disclosed	Not disclosed	Disclosure SEC source: 0001123292-19-000572 · edgar.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. Read SEC document
March 08, 2019 Filed Mar 18, 2019 21:25 UTC	PRECIGEN, INC. XON · Entity 4356	GrantOption to Purchase Common Stock (Right to Buy) · Derivative	42,450	$0.00 Strike: $5.06	$0.00	Disclosure SEC source: 0001123292-19-000526 · edgar.xml · derivative · entry 3 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,450 Underlying: Common Stock · 42,450 shares Expires 2029-03-08 Read SEC document
March 08, 2019 Filed Mar 18, 2019 21:25 UTC	PRECIGEN, INC. XON · Entity 4356	GrantRestricted Stock Units · Derivative	24,703	$0.00	$0.00	Disclosure SEC source: 0001123292-19-000526 · edgar.xml · derivative · entry 2 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,614 Underlying: Common Stock · 24,703 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vest in full one year from the grant date. F3 · derivative.expiration_date: The restricted stock units vest in full one year from the grant date. Read SEC document
March 08, 2019 Filed Mar 18, 2019 21:25 UTC	PRECIGEN, INC. XON · Entity 4356	GrantCommon Stock	11,166	$5.06	$56,499.96	Disclosure SEC source: 0001123292-19-000526 · edgar.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,447 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $56,500. Read SEC document
June 14, 2018 Filed Jun 18, 2018 14:29 UTC	WARNER MEDIA, LLC TWX · Entity 15757	Disposition to issuerPhantom Stock Units · Derivative	1,128.3387	Not disclosed	Not disclosed	Disclosure SEC source: 0000950157-18-000724 · form4.xml · derivative · entry 10 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Deferred Compensation Plan Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 1,128.3387 shares Expires 2018-06-14 F3 · derivative.exercise_price: Pursuant to the Merger Agreement, each outstanding phantom stock unit with respect to the Company's common stock acquired pursuant to the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") was deemed converted into an amount in cash equal to approximately $100.8845 and reinvested in the investment option under the Deferred Compensation Plan that earns interest at a specified rate. Pursuant to the terms of the Deferred Compensation Plan, the amount credited to the account will be paid out in cash in a lump sum or in annual installments beginning on April 30, 2019. F1 · kind: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F3 · price: Pursuant to the Merger Agreement, each outstanding phantom stock unit with respect to the Company's common stock acquired pursuant to the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") was deemed converted into an amount in cash equal to approximately $100.8845 and reinvested in the investment option under the Deferred Compensation Plan that earns interest at a specified rate. Pursuant to the terms of the Deferred Compensation Plan, the amount credited to the account will be paid out in cash in a lump sum or in annual installments beginning on April 30, 2019. Read SEC document
June 14, 2018 Filed Jun 18, 2018 14:29 UTC	WARNER MEDIA, LLC TWX · Entity 15757	Disposition to issuerDirector Stock Options (Right to Buy) · Derivative	2,460	Not disclosed Strike: $88.00	Not disclosed	Disclosure SEC source: 0000950157-18-000724 · form4.xml · derivative · entry 9 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 2,460 shares Expires 2025-06-19 F1 · kind: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F2 · price: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757). F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757). Read SEC document
June 14, 2018 Filed Jun 18, 2018 14:29 UTC	WARNER MEDIA, LLC TWX · Entity 15757	Disposition to issuerDirector Stock Options (Right to Buy) · Derivative	3,108	Not disclosed Strike: $72.37	Not disclosed	Disclosure SEC source: 0000950157-18-000724 · form4.xml · derivative · entry 8 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 3,108 shares Expires 2026-06-17 F1 · kind: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F2 · price: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757). F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757). Read SEC document
June 14, 2018 Filed Jun 18, 2018 14:29 UTC	WARNER MEDIA, LLC TWX · Entity 15757	Disposition to issuerDirector Stock Options (Right to Buy) · Derivative	2,996	Not disclosed Strike: $56.83	Not disclosed	Disclosure SEC source: 0000950157-18-000724 · form4.xml · derivative · entry 7 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 2,996 shares Expires 2023-05-23 F1 · kind: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F2 · price: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757). F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757). Read SEC document
June 14, 2018 Filed Jun 18, 2018 14:29 UTC	WARNER MEDIA, LLC TWX · Entity 15757	Disposition to issuerDirector Stock Options (Right to Buy) · Derivative	2,898	Not disclosed Strike: $67.84	Not disclosed	Disclosure SEC source: 0000950157-18-000724 · form4.xml · derivative · entry 6 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 2,898 shares Expires 2024-06-13 F1 · kind: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F2 · price: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757). F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757). Read SEC document
June 14, 2018 Filed Jun 18, 2018 14:29 UTC	WARNER MEDIA, LLC TWX · Entity 15757	Disposition to issuerDirector Stock Options (Right to Buy) · Derivative	4,880	Not disclosed Strike: $35.27	Not disclosed	Disclosure SEC source: 0000950157-18-000724 · form4.xml · derivative · entry 5 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 4,880 shares Expires 2021-05-20 F1 · kind: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F2 · price: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757). F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757). Read SEC document
June 14, 2018 Filed Jun 18, 2018 14:29 UTC	WARNER MEDIA, LLC TWX · Entity 15757	Disposition to issuerDirector Stock Options (Right to Buy) · Derivative	5,336	Not disclosed Strike: $33.81	Not disclosed	Disclosure SEC source: 0000950157-18-000724 · form4.xml · derivative · entry 4 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 5,336 shares Expires 2022-05-15 F1 · kind: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F2 · price: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757). F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757). Read SEC document
June 14, 2018 Filed Jun 18, 2018 14:29 UTC	WARNER MEDIA, LLC TWX · Entity 15757	Disposition to issuerDirector Stock Options (Right to Buy) · Derivative	5,708	Not disclosed Strike: $28.84	Not disclosed	Disclosure SEC source: 0000950157-18-000724 · form4.xml · derivative · entry 3 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 5,708 shares Expires 2020-05-21 F1 · kind: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F2 · price: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757). F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757). Read SEC document
June 14, 2018 Filed Jun 18, 2018 14:29 UTC	WARNER MEDIA, LLC TWX · Entity 15757	Disposition to issuerDirector Stock Options (Right to Buy) · Derivative	4,019	Not disclosed Strike: $27.39	Not disclosed	Disclosure SEC source: 0000950157-18-000724 · form4.xml · derivative · entry 2 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 4,019 shares Expires 2019-10-28 F1 · kind: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F2 · price: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757). F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a "Company Option"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757). Read SEC document
June 14, 2018 Filed Jun 18, 2018 14:29 UTC	WARNER MEDIA, LLC TWX · Entity 15757	Disposition to issuerCommon Stock, Par Value $.01	49,089	Not disclosed	Not disclosed	Disclosure SEC source: 0000950157-18-000724 · form4.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. F1 · price: On June 14, 2018, AT&T Inc., a Delaware corporation ("AT&T"), acquired Time Warner Inc. (the "Company") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the "Merger Agreement"). The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017. In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash. Each disposition reported in this Form 4 is an exempt disposition. Read SEC document
June 01, 2018 Filed Jun 4, 2018 17:06 UTC	WARNER MEDIA, LLC TWX · Entity 15757	Exercise / conversionRestricted Stock Units · Derivative	2,117	$0.00	$0.00	Disclosure SEC source: 0001127602-18-019804 · form4.xml · derivative · entry 2 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 2,117 shares Expires 2018-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The Reporting Person received one share of common stock for each restricted stock unit that vested. Read SEC document
June 01, 2018 Filed Jun 4, 2018 17:06 UTC	WARNER MEDIA, LLC TWX · Entity 15757	Exercise / conversionCommon Stock, Par Value $.01	2,117	$0.00	$0.00	Disclosure SEC source: 0001127602-18-019804 · form4.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The common stock was acquired as a result of the vesting of restricted stock units awarded on June 16, 2017. F2 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The Reporting Person received one share of common stock for each restricted stock unit that vested. Read SEC document
May 01, 2018 Filed May 2, 2018 16:59 UTC	WARNER MEDIA, LLC TWX · Entity 15757	GrantPhantom Stock Units · Derivative	4.7926	$94.36	$452.23	Disclosure SEC source: 0001127602-18-016005 · form4.xml · derivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Deferred Compensation Plan Disclosed balance after: 1,128.3387 Underlying: Common Stock, Par Value $.01 · 4.7926 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") in connection with the Issuer's quarterly cash dividend payment on its common stock. This transaction is exempt under Section 16(b). Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director. The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account. F1 · derivative.exercise_date: The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") in connection with the Issuer's quarterly cash dividend payment on its common stock. This transaction is exempt under Section 16(b). Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director. The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account. F1 · derivative.expiration_date: The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") in connection with the Issuer's quarterly cash dividend payment on its common stock. This transaction is exempt under Section 16(b). Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director. The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account. Read SEC document
April 27, 2018 Filed May 1, 2018 22:37 UTC	AMGEN INC AMGN · Entity 2832	GrantCommon Stock	1,127	$0.00	$0.00	Disclosure SEC source: 0001127602-18-015809 · form4.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,218 Read SEC document
March 23, 2018 Filed Mar 29, 2018 21:54 UTC	PRECIGEN, INC. XON · Entity 4356	GrantOption to Purchase Common Stock (Right to Buy) · Derivative	14,246	$0.00 Strike: $15.80	$0.00	Disclosure SEC source: 0001123292-18-000596 · edgar.xml · derivative · entry 3 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,246 Underlying: Common Stock · 14,246 shares Expires 2028-03-23 Read SEC document
March 23, 2018 Filed Mar 29, 2018 21:54 UTC	PRECIGEN, INC. XON · Entity 4356	GrantRestricted Stock Units · Derivative	7,911	$0.00	$0.00	Disclosure SEC source: 0001123292-18-000596 · edgar.xml · derivative · entry 2 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,911 Underlying: Common Stock · 7,911 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vest in full one year from the grant date. F3 · derivative.expiration_date: The restricted stock units vest in full one year from the grant date. Read SEC document
March 23, 2018 Filed Mar 29, 2018 21:54 UTC	PRECIGEN, INC. XON · Entity 4356	GrantCommon Stock	3,575	$15.80	$56,485.00	Disclosure SEC source: 0001123292-18-000596 · edgar.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,281 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $56,500. Read SEC document
February 01, 2018 Filed Feb 2, 2018 16:55 UTC	WARNER MEDIA, LLC TWX · Entity 15757	GrantPhantom Stock Units · Derivative	4.6476	$96.90	$450.35	Disclosure SEC source: 0001127602-18-003783 · form4.xml · derivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Deferred Compensation Plan Disclosed balance after: 1,123.5461 Underlying: Common Stock, Par Value $.01 · 4.6476 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") in connection with the Issuer's quarterly cash dividend payment on its common stock. This transaction is exempt under Section 16(b). Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director. The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account. F1 · derivative.exercise_date: The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") in connection with the Issuer's quarterly cash dividend payment on its common stock. This transaction is exempt under Section 16(b). Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director. The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account. F1 · derivative.expiration_date: The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") in connection with the Issuer's quarterly cash dividend payment on its common stock. This transaction is exempt under Section 16(b). Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director. The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account. Read SEC document
November 01, 2017 Filed Nov 2, 2017 17:00 UTC	WARNER MEDIA, LLC TWX · Entity 15757	GrantPhantom Stock Units · Derivative	4.5558	$98.45	$448.52	Disclosure SEC source: 0001127602-17-031018 · form4.xml · derivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Deferred Compensation Plan Disclosed balance after: 1,118.8985 Underlying: Common Stock, Par Value $.01 · 4.5558 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") in connection with the Issuer's quarterly cash dividend payment on its common stock. This transaction is exempt under Section 16(b). Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director. The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account. F1 · derivative.exercise_date: The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") in connection with the Issuer's quarterly cash dividend payment on its common stock. This transaction is exempt under Section 16(b). Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director. The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account. F1 · derivative.expiration_date: The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") in connection with the Issuer's quarterly cash dividend payment on its common stock. This transaction is exempt under Section 16(b). Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director. The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account. Read SEC document
August 01, 2017 Filed Aug 2, 2017 16:59 UTC	WARNER MEDIA, LLC TWX · Entity 15757	GrantPhantom Stock Units · Derivative	4.3528	$102.64	$446.77	Disclosure SEC source: 0001127602-17-024752 · form4.xml · derivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Deferred Compensation Plan Disclosed balance after: 1,114.3427 Underlying: Common Stock, Par Value $.01 · 4.3528 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") in connection with the Issuer's quarterly cash dividend payment on its common stock. This transaction is exempt under Section 16(b). Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director. The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account. F1 · derivative.exercise_date: The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") in connection with the Issuer's quarterly cash dividend payment on its common stock. This transaction is exempt under Section 16(b). Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director. The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account. F1 · derivative.expiration_date: The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") in connection with the Issuer's quarterly cash dividend payment on its common stock. This transaction is exempt under Section 16(b). Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director. The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account. Read SEC document
June 16, 2017 Filed Jun 20, 2017 17:07 UTC	WARNER MEDIA, LLC TWX · Entity 15757	GrantRestricted Stock Units · Derivative	2,117	$0.00	$0.00	Disclosure SEC source: 0001127602-17-021900 · form4.xml · derivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,117 Underlying: Common Stock, Par Value $.01 · 2,117 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The Reporting Person receives one share of common stock for each restricted stock unit that vests. F2 · derivative.exercise_date: This award of restricted stock unit vests in full on June 1, 2018. The vested shares of common stock will be issued to the Reporting Person upon vesting. F2 · derivative.expiration_date: This award of restricted stock unit vests in full on June 1, 2018. The vested shares of common stock will be issued to the Reporting Person upon vesting. Read SEC document
June 15, 2017 Filed Jun 19, 2017 17:04 UTC	WARNER MEDIA, LLC TWX · Entity 15757	GrantPhantom Stock Units · Derivative	1,109.9899	$0.00	$0.00	Disclosure SEC source: 0001127602-17-021777 · form4.xml · derivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Deferred Compensation Plan Disclosed balance after: 1,109.9899 Underlying: Common Stock, Par Value $.01 · 1,109.9899 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock units were acquired by the Reporting Person in a transaction exempt under Section 16(b) pursuant to the terms of the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") and are to be settled in cash in a lump sum or in annual installments beginning on April 30th following the date the Reporting Person ceases to be a director. The cash value received by the Reporting Person upon distribution will be based, one-for-one, upon the fair market value of the Common Stock underlying the phantom stock units held in the Reporting Person's account. F1 · derivative.exercise_date: The phantom stock units were acquired by the Reporting Person in a transaction exempt under Section 16(b) pursuant to the terms of the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") and are to be settled in cash in a lump sum or in annual installments beginning on April 30th following the date the Reporting Person ceases to be a director. The cash value received by the Reporting Person upon distribution will be based, one-for-one, upon the fair market value of the Common Stock underlying the phantom stock units held in the Reporting Person's account. F1 · derivative.expiration_date: The phantom stock units were acquired by the Reporting Person in a transaction exempt under Section 16(b) pursuant to the terms of the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") and are to be settled in cash in a lump sum or in annual installments beginning on April 30th following the date the Reporting Person ceases to be a director. The cash value received by the Reporting Person upon distribution will be based, one-for-one, upon the fair market value of the Common Stock underlying the phantom stock units held in the Reporting Person's account. F1 · ownership.nature: The phantom stock units were acquired by the Reporting Person in a transaction exempt under Section 16(b) pursuant to the terms of the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the "Deferred Compensation Plan") and are to be settled in cash in a lump sum or in annual installments beginning on April 30th following the date the Reporting Person ceases to be a director. The cash value received by the Reporting Person upon distribution will be based, one-for-one, upon the fair market value of the Common Stock underlying the phantom stock units held in the Reporting Person's account. Read SEC document
June 01, 2017 Filed Jun 2, 2017 14:43 UTC	WARNER MEDIA, LLC TWX · Entity 15757	Exercise / conversionRestricted Stock Units · Derivative	1,382	$0.00	$0.00	Disclosure SEC source: 0001127602-17-020249 · form4.xml · derivative · entry 2 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, Par Value $.01 · 1,382 shares Expires 2017-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The Reporting Person received one share of common stock for each restricted stock unit that vested. Read SEC document
June 01, 2017 Filed Jun 2, 2017 14:43 UTC	WARNER MEDIA, LLC TWX · Entity 15757	Exercise / conversionCommon Stock, Par Value $.01	1,382	$0.00	$0.00	Disclosure SEC source: 0001127602-17-020249 · form4.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The common stock was acquired as a result of the vesting of restricted stock units awarded on June 18, 2016. F2 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The Reporting Person received one share of common stock for each restricted stock unit that vested. Read SEC document
May 01, 2017 Filed May 4, 2017 00:26 UTC	AMGEN INC AMGN · Entity 2832	GrantCommon Stock	1,230	$0.00	$0.00	Disclosure SEC source: 0001127602-17-016733 · form4.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,091 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. Read SEC document
March 16, 2017 Filed Mar 20, 2017 20:22 UTC	PRECIGEN, INC. XON · Entity 4356	GrantOption to Purchase Common Stock (Right to Buy) · Derivative	15,000	$0.00 Strike: $21.38	$0.00	Disclosure SEC source: 0001225385-17-000051 · edgar.xml · derivative · entry 2 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-03-16 Read SEC document
March 16, 2017 Filed Mar 20, 2017 20:22 UTC	PRECIGEN, INC. XON · Entity 4356	GrantCommon Stock	2,806	$0.00	$0.00	Disclosure SEC source: 0001225385-17-000051 · edgar.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,706 Read SEC document
December 01, 2016 Filed Dec 5, 2016 16:14 UTC	PRECIGEN, INC. XON · Entity 4356	PurchaseCommon Stock	6,900	$29.02	$200,266.29	Disclosure SEC source: 0001225385-16-000084 · edgar.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,900 F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $28.86 to $29.14, inclusive. The reporting person undertakes to provide Intrexon Corporation ("Intrexon"), any security holder of Intrexon, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document
May 03, 2016 Filed May 5, 2016 23:59 UTC	AMGEN INC AMGN · Entity 2832	GrantCommon Stock	1,279	$0.00	$0.00	Disclosure SEC source: 0001127602-16-051278 · form4.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,861 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. Read SEC document
August 19, 2015 Filed Aug 20, 2015 21:58 UTC	AMGEN INC AMGN · Entity 2832	PurchaseCommon Stock	10	$165.50	$1,655.00	Disclosure SEC source: 0001127602-15-025541 · form4.xml · nonDerivative · entry 2 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,582 Read SEC document
August 19, 2015 Filed Aug 20, 2015 21:58 UTC	AMGEN INC AMGN · Entity 2832	PurchaseCommon Stock	3,000	$166.64	$499,907.10	Disclosure SEC source: 0001127602-15-025541 · form4.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,572 F1 · price: The price reported is an average price. The prices ranged from $166.51 to $166.76 per share. Full information regarding the number of shares purchased at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document
August 04, 2015 Filed Aug 6, 2015 20:47 UTC	AMGEN INC AMGN · Entity 2832	GrantCommon Stock	572	$0.00	$0.00	Disclosure SEC source: 0001127602-15-024372 · form4.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572 F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur accrding to the elected deferral schedule. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.